share_log

B of A Securities Maintains Buy on Neumora Therapeutics, Lowers Price Target to $7

B of A Securities Maintains Buy on Neumora Therapeutics, Lowers Price Target to $7

美国银行证券维持对Neumora Therapeutics的买入评级,目标价下调至7美元
Benzinga ·  01/06 19:42  · 评级/大行评级

B of A Securities analyst Geoff Meacham maintains Neumora Therapeutics (NASDAQ:NMRA) with a Buy and lowers the price target from $22 to $7.

b of A Securities分析师杰夫·米查姆维持Neumora Therapeutics(纳斯达克股票代码:NMRA)的买入并将目标股价从22美元下调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发